Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:56 PM
Ignite Modification Date:
2025-12-24 @ 4:56 PM
NCT ID:
NCT04520750
Eligibility Criteria:
Key Inclusion Criteria:
* Adult patients 18 years or older,
* Previously completed the VALO protocol, or VALO-2 K6C/17 sub-study, and received meaningful benefit from investigational PTX-022 as determined by the clinician.
Key Exclusion Criteria:
* Any history of allergy or hypersensitivity to sirolimus, or sirolimus-like medications or to PTX-022
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04520750
Study Brief:
Protocol Section:
NCT04520750